International Journal of Drug Policy10.1016/j.drugpo.2021.103139202193103139Post-Brexit opportunities for tobacco policy reform and tobacco harm reduction in the UKGerry V. Stimson,
Drug and Alcohol Review10.1111/j.1465-3362.2010.00264.x2011302119-123Tobacco, nicotine and harm reductionJACQUES LE HOUEZEC, ANN MCNEILL, JOHN BRITTON,
International Journal of Drug Policy10.1016/j.drugpo.2005.04.0022005163139-142The prospects for tobacco harm reductionWayne D. Hall,
Toxicological Evaluation of Electronic Nicotine Delivery Products10.1016/b978-0-12-820490-0.00001-820211-15Tobacco Harm Reduction Concepts and Policy ApproachesMarc S. Firestone, Manuel C. Peitsch,
International Journal of Drug Policy10.1016/s0955-3959(98)00029-2199894247-253Tobacco harm reduction policies: the debate in QuebecL. Beauchesne,
International Journal of Drug Policy10.1016/j.drugpo.2009.10.0082010212129-130Harm reduction policies for tobacco usersCoral Gartner, Wayne Hall,
International Journal of Drug Policy10.1016/j.drugpo.2015.02.0012015266543-547Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenariosLynn T. Kozlowski,
International Journal of Drug Policy10.1016/j.drugpo.2006.11.013200718270-74Tobacco harm reduction: How rational public policy could transform a pandemicDavid Sweanor, Philip Alcabes, Ernest Drucker,
Sociology of Health & Illness10.1111/j.1467-9566.2012.01485.x2012353361-376Harm reduction and the medicalisation of tobacco useCatriona Rooke,
International Journal of Drug Policy10.1016/j.drugpo.2015.01.0182015266575-582Harm reduction in U.S. tobacco control: Constructions in textual news mediaMichael H. Eversman,